Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 7,695 | 7,690 | 7,876 | 5,729 | 1,260 |
| Gross Profit | 7,695 | 7,690 | 7,876 | 5,729 | 1,260 |
| Operating Expenses | 43,808 | 80,738 | 84,072 | 96,050 | 94,048 |
| Operating Income | -36,113 | -73,048 | -76,196 | -90,321 | -92,788 |
| Other Income | 2,737 | 9,930 | 6,999 | 2,223 | -5,803 |
| Pre-tax Income | -33,376 | -63,118 | -69,197 | -88,098 | -98,591 |
| Net Income Continuous | -33,376 | -63,118 | -69,197 | -88,098 | -98,591 |
| Net Income | $-33,376 | $-63,118 | $-69,197 | $-88,098 | $-98,591 |
| EPS Basic Total Ops | -17.85 | -33.06 | -36.60 | -47.20 | -59.40 |
| EPS Basic Continuous Ops | -17.85 | -33.06 | -36.60 | -47.16 | -59.40 |
| EPS Diluted Total Ops | -17.85 | -33.06 | -36.60 | -47.20 | -59.40 |
| EPS Diluted Continuous Ops | -17.85 | -33.06 | -36.60 | -47.16 | -59.40 |
| EPS Diluted Before Non-Recurring Items | -17.85 | -32.20 | -36.60 | -47.20 | -59.40 |
| EBITDA(a) | $-35,492 | $-73,882 | $-78,835 | $-88,471 | $-88,941 |